Moreover, pharmacological inhibition of FASN in HER2-positive breast cancer cells resulted in the accumulation of ETV4/PEA3, a transcriptional repressor of the HER2 gene, and reduced HER2 transcript and protein levels [39]. Here, ERBB2 is linked to breast cancer.